Random Trial for Elderly Patients With NSCLC

Sponsor
Inje University
Study ID
NCT00265694
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

1. Recently a radomized trial of vinorelbine versus best supportive care in patients at 70 years of age or older demonstrated a definite improvement in overall survival rate and quality of life with chemotherapy. 2. The role of combination therapy containing the platinum compound, which is the standard therapy for the young patients is still vague. 3. Gemcitabine and carboplatin have favorable toxicity profile.

Key Dates

Status verified
Jun 2005

Study Design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Central Contacts

Related Studies